🚀 NBIS $4.3M LEAP Call Bet Before May 13 Earnings — Whale Targets $250 on AI Cloud Hyperscale Ramp

Ticker: NBIS — Nebius Group N.V. (NASDAQ) Trade Date: May 6, 2026 Spot Price at Print: $191.28 Sector: AI Infrastructure / Neocloud GPU-as-a-Service

---

The Quick Take

A single whale paid $4.3 million in premium at 12:39 ET on May 6, 2026 to open a Buy to Open (BTO) long call position on NBIS at the $250 strike expiring January 15, 2027 — a classic 8.3-month LEAP structure. The contract printed at a volume-to-OI ratio of 16.2x (1,100 contracts vs. 68 open interest), confirming this as aggressive new opening interest rather than a roll or close. With spot at $191.28, the $250 strike sits ~31% out of the money, and the full breakeven lands at $292.69 — a ~53% rally from the print price needed by January expiration. This is not a cautious hedge. It is a directional, high-conviction bet that Nebius's AI cloud hyperscale ramp will deliver a re-rating above $250 within the next eight months.

The timing is deliberate: Q1 2026 earnings land in exactly seven calendar days on May 13, 2026 before market open, and the company is sitting on one of the densest near-term catalyst stacks in AI infrastructure — a $7B Microsoft upfront payment confirmed May 4, a freshly signed $27B Meta contract, a $2B NVIDIA strategic investment committing 5 GW of forward compute, a $643M Eigen AI inference acquisition announced May 1, and management guiding to a $7–9B exit ARR run-rate by year-end 2026. The whale is buying the thesis that all of this converts into a blow-out print on May 13 and a multi-catalyst re-rating through year-end.

---

YTD Performance

📈 Gamma-Based Support & Resistance

Current Price: $193.83

🔵 Support levels (GEX-based dealer zones):

• $190.00 — net GEX +2.13M, 1.98% below spot ($193.83)
• $185.00 — net GEX +1.03M, 4.56% below spot ($193.83)
• $180.00 — net GEX +1.69M, 7.14% below spot ($193.83)
• $175.00 — net GEX +1.17M, 9.71% below spot ($193.83)
• $170.00 — net GEX +0.66M, 12.29% below spot ($193.83)

🟠 Resistance levels (GEX-based dealer zones):

• $200.00 — net GEX +6.06M, 3.18% above spot ($193.83)
• $210.00 — net GEX +0.98M, 8.34% above spot ($193.83)
• $220.00 — net GEX +0.98M, 13.50% above spot ($193.83)

With spot at $193.83, the closest GEX wall above is $200.00 (3.18% away) and the closest gamma floor below is $190.00 (1.98% away). Dealers are positioned to dampen volatility around these levels in normal flow.

🎯 Implied Move Analysis

Options market pricing from ~$193.84:

These ranges represent one-standard-deviation moves implied by ATM straddle prices. Roughly 68% of historical outcomes fall inside the band — meaning ~1 in 3 expirations break out of the range. Use these as guideposts, not guarantees.

Note: Gamma exposure (GEX) support/resistance chart and implied move visualization are not available for this date and have been omitted.

---

Tape Breakdown

The 16.2x vol/OI ratio is the signature of a fresh institutional opener, not a roll. With only 68 contracts of existing open interest, the 1,100-contract print created the position. The $4.3M premium outlay in a single ticket at 12:39 ET — well into the session, not a pre-market or open-print artifact — suggests deliberate, price-insensitive buying. This is the behavior of a fund or desk with a strong directional conviction into the May 13 earnings event and beyond.

---

Risk / Reward Profile

This is a defined-risk, unlimited-upside BTO long call. The buyer paid $4.3M in premium and that is the maximum loss — capital paid disappears entirely if NBIS closes below $250 on January 15, 2027. There is no further obligation and no margin requirement beyond the premium.

The asymmetry is the point. The buyer risks a fixed $4.3M for exposure to a potential multi-hundred-percent gain if NBIS re-rates to match its contracted backlog ($46–50B) against a current $44B market cap. Even a move to Goldman's $205 price target would leave the contract OTM, so the whale is betting on a scenario materially above current sell-side consensus. The $250 strike and January 2027 expiry align with a view that Q1 earnings plus subsequent capacity ramp milestones will drive a step-change re-rating in the second half of 2026.

---

Greeks Snapshot (Estimated)

Note: Live Greeks are not available for this print. The following are directional estimates based on a 31% OTM call with ~254 days to expiration, using implied volatility consistent with NBIS's recent high-volatility profile (IV estimated in the 75–90% range).

The single most important Greek risk for this trade is vega. NBIS will experience a sharp implied volatility crush immediately after the May 13 earnings print, regardless of direction. The LEAP structure mitigates this more than a near-term contract would — the January 2027 expiry means the vol crush hits only the front-end of the term structure, while long-dated vols decay more slowly. Still, a trader holding through earnings must expect an IV headwind even on a positive stock reaction.

The second key dynamic is delta evolution. At 31% OTM, the current delta of ~0.30–0.35 means the position has only partial leverage to the upside move. If NBIS rallies sharply to $220–$230 on earnings, delta accelerates toward 0.45–0.55, materially improving the position's sensitivity. If the stock sells off or stagnates, delta bleeds lower and the trade becomes increasingly dependent on a late-2026 catalyst rather than the May 13 print.

---

Catalyst Stack — Why This Trade Makes Sense Now

The timing of this BTO is inseparable from the extraordinary density of near-term and medium-term catalysts stacking into the January 2027 expiry window.

Q1 2026 Earnings — May 13, 2026 (7 Days Away)

The single most immediate catalyst. Q1 2026 earnings are confirmed for May 13, 2026 before market open, with a conference call at 8:00 a.m. ET. Consensus revenue sits at ~$375M, implying ~65% sequential growth from Q4's $227.7M. The key metrics beyond the headline number are:

• AI Cloud revenue mix and sequential growth rate — the market is underwriting 830% YoY growth continuation from Q4
• End-of-Q1 ARR run-rate — consensus appears to be tracking toward $2.0–2.5B, a substantial step up from the $1.25B exit-2025 print
• Megawatts connected — the bridge from 170 MW (exit-2025) toward the 800–1,000 MW year-end target is the primary execution proof point
• Microsoft revenue recognition cadence — with $7B in upfront cash confirmed May 4, analysts will want to understand how and when this cash flows through the P&L
• Gross margin trajectory — early-stage GPU cloud deployments carry high depreciation; any improvement in GM% signals scale operating leverage

NBIS missed the Q4 2025 consensus by ~8%, and that miss was flagged by multiple analysts as a risk factor. A repeat miss against the $375M Q1 bar would punish the multiple and torch this LEAP. Conversely, a beat-and-raise — which the Microsoft cash, Meta ramp, and Eigen AI deal collectively support — would likely send spot toward the $200–$220 range and begin compressing the distance to breakeven.

NVIDIA $2B Strategic Investment + 5 GW Commitment

On March 11, 2026, NVIDIA announced a $2B private placement of pre-funded warrants in Nebius (~21M shares at near-zero strike) paired with a commitment to deploy more than 5 GW of NVIDIA systems by 2030 and early access to the next-generation Rubin platform, Vera CPUs, and BlueField storage. This is structurally transformative: it makes NVIDIA a financially aligned equity holder in Nebius's success — NVIDIA's own stock price benefits from Nebius deploying more GPU capacity faster. The preferential access to Rubin/Vera systems is a durable competitive moat against CoreWeave, Lambda, and other neoclouds competing on NVIDIA allocations.

Meta $27B Multi-Year Contract

Signed March 16, 2026, the Meta deal — $12B in dedicated capacity plus up to $15B optional incremental — is one of the largest AI infrastructure contracts ever announced. It builds on an earlier $3B Meta agreement from December 2025 and includes one of the first large-scale deployments of NVIDIA's Vera Rubin next-generation chips. At 14% of Nebius's total announced backlog (~$46–50B), Meta is the second anchor customer behind Microsoft. The stock moved +14% on the day of the announcement.

Microsoft $19.4B Contract + $7B Upfront Cash

The foundational contract of the Nebius bull thesis. The full $19.4B / 5-year agreement was originally signed in September 2025. The newest update — confirmed May 4, 2026, just two days before this LEAP was purchased — is a $7B upfront payment commitment, a significant de-risking of the revenue stream. The stock closed +12% on May 4. The whale purchasing the January 2027 LEAP on May 6 was doing so against the backdrop of that fresh validation.

Eigen AI Acquisition ($643M) — May 1, 2026

The $643M cash-and-stock acquisition of Eigen AI (~$98M cash + 3.8M shares) adds an MIT-rooted 20-person inference-optimization team to Nebius Token Factory, establishing a new San Francisco engineering hub and accelerating the inference moat that differentiates Nebius from pure-hardware neoclouds. Bloomberg reported the deal positions Nebius to make AI run faster and cheaper, and the stock moved +12–14% on the announcement. The acquisition is expected to close mid-2026 — within the LEAP window.

Finland 310 MW AI Factory — March 31, 2026

A $10B investment in Lappeenranta, Finland via Polarnode partnership representing one of Europe's largest AI factory announcements. First customer supply is targeted 2027. This is a long-horizon capacity unlock, but within the January 2027 LEAP window, milestones such as site preparation completion, grid interconnect approvals, and early equipment arrivals would each serve as positive catalysts.

FY2026 Guidance: $3.0–3.4B Revenue, $7–9B Exit ARR

Management's own guidance implies a near-7x revenue ramp from 2025's $530M to the midpoint of the 2026 range. The $7–9B exit ARR target for December 2026 is the critical bull case anchor. If the company exits 2026 at $8B ARR, applying even a modest 10x ARR multiple implies an $80B market cap versus today's $44B — roughly double the current market cap, or a stock price in the $350–$360 range. That scenario would place this LEAP deep in the money.

---

Analyst Landscape

The sell-side picture is broadly bullish but with significant price target dispersion, reflecting genuine uncertainty about execution and valuation methodology.

A notable observation: the consensus PT of ~$163 is already below the current $191 spot price, and Goldman's bull-case $205 PT is still ~38% below the $250 LEAP strike. The whale is not trading sell-side price targets. They are trading the potential for a valuation regime shift driven by executed ARR delivery — a scenario where NBIS gets repriced on a revenue multiple consistent with hypergrowth AI cloud, rather than the current estimates. This is a high-conviction bet against the consensus.

---

Short Interest Dynamic

With 17.1% of float short (~43M shares, 3.4 days to cover) as tracked by MarketBeat, NBIS carries one of the highest short floats in the AI infrastructure peer group. This is a double-edged setup:

• Squeeze risk on a beat: An in-line or beat Q1 print on May 13 could trigger forced short covering, creating an amplified rally. At 3.4 days to cover, a strong print has the mechanical ingredients for a squeeze.
• Bearish conviction signal: The elevated short interest also reflects genuine institutional skepticism about execution on the 800–1,000 MW capacity target, customer concentration in Microsoft and Meta, and the $4.34B convertible overhang.

For the LEAP buyer, the short interest is a potential tailwind into earnings — a squeeze that drives spot sharply higher would both improve intrinsic value and keep long-dated vols elevated through the position, limiting the vega crush.

---

Key Risk Factors

This trade carries real and significant risks that must be understood before drawing any conclusions about its merit.

1. Maximum Loss = $4.3M (Full Premium) The LEAP expires worthless if NBIS closes below $250 on January 15, 2027. Given a current spot of $191.28 and a $292.69 breakeven, the stock must rally ~53% from today's price to generate any profit at expiration. Even a rally to Goldman's $205 PT would leave the position approximately $4.3M in the red on a hold-to-expiry basis.

2. Vega Risk Around May 13 Earnings Implied volatility is elevated pre-earnings. Post-earnings IV crush will hit the LEAP position even on a positive move. A trader buying this LEAP today is long vega — if the stock rallies but IV falls sharply (the typical pattern), the net P&L can disappoint relative to the stock move alone. The January 2027 expiry provides substantial buffer (long-dated vols crush less than near-term), but the effect is non-zero.

3. Execution Risk on Capacity Ramp The 170 MW → 800–1,000 MW target in a single calendar year requires flawless GPU delivery, power interconnects, data center fit-out, and customer onboarding across multiple geographies. Any slip — GPU allocation shortfall, grid permitting delay, customer push-out — directly pressures the $7–9B exit ARR target and the implied re-rating thesis.

4. Customer Concentration Microsoft and Meta likely represent >70% of medium-term backlog. Loss, renegotiation, or even a performance dispute under either contract would be materially impairment to the bull case and to this position.

5. Capital Dilution The $4.34B convertible offering plus the NVIDIA $2B warrant issuance have added $96M+ in annual interest cost and meaningful dilution to the share count. With $16–20B of FY26 capex against $3.7B of starting cash, further equity or debt raises are likely — each one a potential dilutive headwind to per-share valuation.

6. Q1 Miss Risk NBIS missed Q4 2025 consensus by ~8%. A repeat miss against the $375M Q1 bar — especially given the high sequential growth assumption — would punish the multiple and likely send the stock back toward the $150–$170 range, materially damaging the LEAP position.

7. Insider Selling Director Elena Bunina sold 20,060 shares between $140–$161 in April 2026 plus 5,882 shares on May 4. CIO Andrey Korolenko sold 58,333 shares (~$6.15M) over six months. 10b5-1 plan sales are common and not inherently bearish, but the pattern warrants monitoring.

---

Market Position and Competitive Context

Nebius's bull case rests on a moat that is increasingly difficult to replicate:

• NVIDIA alignment: A $2B equity investment from NVIDIA — the monopoly supplier of frontier GPUs — is not a vendor contract; it is a strategic alliance that gives Nebius preferential allocation access through the Blackwell, Rubin, and Vera roadmap cycles. Competitors without this relationship face allocation risk in a supply-constrained market.
• $46–50B contracted backlog: Against 2025 revenue of $530M, the backlog implies ~90x annualized coverage — effectively, demand is not the constraint; execution is. Per The Motley Fool's analysis, this backlog is transformative context for valuation.
• Full-stack differentiation: The combination of GPU compute (NVIDIA Hopper/Blackwell/Rubin), inference optimization (Token Factory + Eigen AI post-acquisition), and European sovereign-friendly footprint (Finland, Iceland, France, UK) is a more defensible stack than pure-hardware neoclouds.
• Competitors: CoreWeave (CRWV), Crusoe, Lambda, and Applied Digital (APLD) compete on the neocloud layer; Azure, AWS, and GCP compete on the hyperscaler end. None of these possess the NVIDIA strategic equity alignment or the combination of contracted backlog scale.

The Goldman Sachs upgrade rationale — lifting PT $45 to $205 post-Meta contract — reflects the view that the backlog de-risks revenue, NVIDIA alignment de-risks supply, and the execution story is becoming more visible. The LEAP buyer is extrapolating that trajectory.

---

Three Trading Ideas

The following ideas are presented for informational and educational purposes only. Options trading involves substantial risk. These are not personalized recommendations. All scenarios are hypothetical and based on the analysis above.

---

Idea 1 — Earnings Straddle Debit (Pre-Earnings Vol Play)

Structure: Buy the May 16 or May 21 ATM straddle (buy ~$190–$195 call + buy ~$190–$195 put, same strike, same expiry) ahead of the May 13 earnings print.

Rationale: NBIS has moved +12–16% on each of the last three major catalyst announcements (NVIDIA, Meta, Eigen). The company has $16–20B of capex planned for 2026, a $375M consensus that implies 65% sequential growth, and 17% short interest that could amplify the move in either direction. If the realized move on earnings exceeds the implied move priced into the straddle, the long straddle profits regardless of direction.

Key risk: If NBIS's realized earnings move is smaller than implied, both the call and put decay rapidly in the IV crush. Post-earnings, the position must be managed promptly. Liquidity in short-dated NBIS options should be verified before entry given the name's growth-stage profile.

Best case: NBIS moves +20% or -15% on earnings, covering the straddle cost (estimated 8–12% of spot) with room to profit.

---

Idea 2 — Bull Call Spread (Defined Risk, Lower Cost Bullish Bet)

Structure: Buy the July 2026 $200 call, sell the July 2026 $240 call. Net debit is a fraction of the LEAP premium with a defined max gain and max loss.

Rationale: For investors who share the whale's directional view but want defined, lower-capital exposure to the May 13 earnings catalyst, a July bull call spread captures the near-term bullish thesis at a significantly lower premium than a LEAP. The $200–$240 spread has a max gain of $40 per share (~$4,000 per contract) at a typical net debit of $8–$14 per share.

Breakeven (estimated): ~$208–$214 at July expiry, meaning NBIS needs only a modest 9–12% rally from $191.28 to reach breakeven — versus the 53% required for the whale's LEAP.

Key risk: The spread caps upside at $240. If NBIS has a blowout earnings and jumps to $230+, the position profits nicely but does not participate in a full rip to $250+. The spread also expires in July, so any bullish thesis that requires 2H catalysts to materialize is not captured.

---

Idea 3 — Synthetic Stock via LEAP Conversion (Delta Ramp Strategy)

Structure: If the May 13 earnings print is positive and the stock trades to $210–$220, consider rolling the existing LEAP long call thesis into a higher-delta position — either by buying a second LEAP at a closer strike (e.g., $220 strike January 2027) to increase delta, or by adding a short put financed by the appreciated call value to create a synthetic long.

Rationale: The current LEAP at $250 strike has a delta of ~0.30–0.35 in a $191 stock environment. If NBIS rallies to $215–$220 on earnings, the $250 strike delta moves toward 0.45–0.55 — a natural acceleration. An investor who wants to own the position at higher delta and lower implied vol (post-earnings crush) could construct a risk reversal or synthetic long at that point, effectively locking in a better entry for the continued hyperscale ramp thesis.

Key risk: This is a second-order tactical decision that requires monitoring the May 13 outcome. Constructing a synthetic long post-earnings at elevated spot introduces more absolute dollar risk if the stock subsequently reverses. Position sizing and stop-loss discipline are essential.

---

Summary

The $4.3M LEAP is the type of trade that only makes sense if the buyer believes Nebius is about to enter a multi-quarter ARR compounding cycle that the current ~$191 stock price does not yet reflect. With $46–50B of contracted backlog, a strategic NVIDIA equity holder, and the densest catalyst calendar in the AI infrastructure complex arriving over the next seven days and the subsequent eight months, the structural case is not hard to construct. The execution risk is real, the dilution overhang is real, and the breakeven is steep — but for a fund willing to define its risk at $4.3M and let the thesis play out through the January 2027 expiry, this LEAP represents a precisely structured, high-conviction expression of the Nebius hyperscale ramp thesis.

---

Options trading involves substantial risk of loss and is not suitable for all investors. This analysis is for informational and educational purposes only and does not constitute personalized investment advice or a recommendation to buy or sell any security. Past performance of similar trades is not indicative of future results. Greeks and probability estimates are approximations based on publicly available information and standard options pricing theory. All premium figures are derived from the trade tape as recorded. Verify current market data, IV levels, and liquidity before entering any position.